Amplifon | AMP - Selling And Administration Expenses

Stock Price
10.93
Daily Change
0.05 0.46%
Monthly
10.09%
Yearly
-44.46%
Q2 Forecast
10.67

Amplifon reported EUR0 in Selling and Administration Expenses for its fiscal quarter ending in December of 2023.





Selling And Administration Expenses Change Date
Avanos Medical USD 77.7M 1.1M Mar/2026
Brookdale Senior Living USD 4.22B 4.19B Mar/2026
Cencora USD 1.8B 46.42M Dec/2025
Diasorin EUR 56M 49.25M Mar/2026
Encompass Health USD 58.2M 10.2M Mar/2026
Enovis USD 282.81M 12.37M Mar/2026
GE HealthCare Technologies USD 1.11B 145M Dec/2025
OPKO Health USD 50.52M 3.28M Dec/2025
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026